Fasting samples support quantitative fatty acid measurement
Gas chromatography with internal standards measures absolute fatty-acid concentrations rather than proportions, reducing dependence on changes in other fatty acids.
↳ Methods §§4.2, 4.4
Maternal obesity in pregnancy is a pro-inflammatory condition exposing the fetus to an adverse environment. Here, we tested associations of maternal obesity (primary exposures: BMI, leptin) and metabolic parameters (secondary exposures: glucose, C-peptide, and insulin sensitivity) with total serum concentrations of fatty acids in the first trimester of human pregnancy. This cross-sectional study included 123 non-smoking women with singleton pregnancy. In maternal serum, cotinine, leptin, and C-peptide (ELISA), glucose (hexokinase-based test) and fatty acids (gas chromatography) were quantified, and the insulin sensitivity index (ISHOMA) was calculated. Concentrations of fatty acid classes and total fatty acids did not differ between BMI or leptin categories. However, n-3 polyunsaturated fatty acids (PUFA) were decreased in the category with the highest C-peptide concentration (n-3 PUFA: CI -35.82--6.28, p < 0.006) and in the lowest ISHOMA category (n-3 PUFA: CI -36.48--5.61, p < 0.008). In a subcohort, in which fetal sex was determined (RT-qPCR of placental tissue), C-peptide was significantly associated with docosahexaenoic acid (DHA) in mothers bearing a female (n = 46), but not male (n = 37) fetus. In conclusion, pregnant women with high fasting C-peptide and low ISHOMA had decreased n-3 PUFA, and DHA was lower with higher C-peptide only in mothers bearing a female fetus.
Pregnant women (week 4+0–11+6) with a high C-peptide concentration and low insulin sensitivity (ISHOMA) had decreased serum concentration of total n-3 PUFA
cross-sectional associations survive the stated multiplicity correction but remain subject to unmeasured dietary confounding
Concentrations of fatty acid classes and total fatty acids did not differ between BMI or leptin categories.
reported category comparisons are null, but few obese participants limit power and do not establish equivalence
C-peptide was significantly associated with docosahexaenoic acid (DHA) in mothers bearing a female (n = 46), but not male (n = 37) fetus.
small selected subgroups and permissive interaction and multiplicity thresholds limit evidence for sex specificity
ISHOMA (continuous) was inversely associated with the n-6/n-3 PUFA ratio (β: −0.59, CI: −1.09–0.87, p = 0.022)
cross-sectional evidence lacks dietary adjustment and contains an unresolved conflict between the printed confidence interval and significance statement
Derived from the full evaluation — not a separate score.
Strengths
Gas chromatography with internal standards measures absolute fatty-acid concentrations rather than proportions, reducing dependence on changes in other fatty acids.
↳ Methods §§4.2, 4.4
The analysis contrasts C-peptide and calculated insulin sensitivity with BMI and leptin, adding targeted observations from the first trimester.
↳ Introduction; Results §§2.1, 2.3
The discussion states that lower n-3 PUFA could be a cause or consequence of altered glucose–insulin metabolism and identifies important cohort limitations.
↳ Discussion §3
Limitations
Diet was not recorded, and recruitment at termination counselling constrains generalization. Determinants of placental-tissue availability for the 83-person fetal-sex subgroup were not examined.
↳ Discussion §3; Results §2.6; Methods §§4.1, 4.7
The nonsmoker cutoff is 0.03 nmol/L despite assay sensitivity of 2.5 nmol/L. Section 2.4 pairs a zero-spanning interval with p = 0.022, and Section 2.5 places coefficient 1.16 outside its interval 0.09–0.22.
↳ Results §§2.4–2.5; Methods §4.3
The abstract's female-only DHA interpretation rests on 46 female-bearing and 37 male-bearing pregnancies, interaction testing at p < 0.1 and multiplicity control at FDR 0.2. These results warrant replication rather than a definitive sex-specific conclusion.
↳ Abstract; Results §2.6; Methods §4.7
The clearest contribution is the association of higher C-peptide and lower calculated insulin sensitivity with lower total n-3 PUFA in early pregnancy. Quantitative fasting assays, covariate adjustment and the high-glucose sensitivity analysis support this result, although ISHOMA incorporates C-peptide and is not an independent confirmation. Unmeasured diet and the selected cohort constrain interpretation, while permissive testing thresholds and small subgroups make the female-specific DHA finding exploratory. The discussion engages relevant metabolic literature and avoids causal conclusions, but its dismissal of dietary influence is insufficient and the numerical reporting requires correction.
Nabu’s assessment, alongside the field’s view.
Are you an author of this paper?
The study adds first-trimester observations distinguishing associations with metabolic markers from comparisons across BMI and leptin categories. Its advance remains incremental, with limited evidence for the null and sex-specific interpretations.
Fasting sampling, quantitative fatty-acid assays, covariate adjustment and a high-glucose sensitivity analysis support the association analysis. Unmeasured diet, selection, permissive testing thresholds and unresolved smoking classification introduce meaningful uncertainty.
The analytic sequence is followable and causal uncertainty is explicitly stated. The abstract's female-only interpretation, broader DHA wording in the conclusions and incompatible numerical reports reduce precision.
The discussion connects the findings to metabolic heterogeneity, insulin sensitivity and fetal-sex literature while acknowledging major cohort limitations. Its argument against dietary confounding does not adequately resolve that limitation.
Caveats4 of 4 checks
The stated cotinine classification threshold is below the assay's reported analytical sensitivity. Ethics approval and written informed consent are declared.
Ethics approval: declared
42 of 42 checkable references verified
43 references in manuscript 1 are books, websites or datasets — counted, but not index-checkable
References not verified automatically are resolved manually within 24 hours.
No retraction or expression of concern found in Crossref (includes Retraction Watch).
Sources: Crossref (incl. Retraction Watch) ✓
The primary claim rests on a single cross-sectional observational association in 123 women, with no controlled experiment or independent replication.
The paper states only that the findings need confirmation in larger cohorts and would add to growing evidence, with no real-world use of its own findings described.
Researchers in maternal-fetal metabolism could replicate these associations in larger cohorts to inform future n-3 PUFA supplementation or insulin-sensitivity studies in pregnancy.
The finding is a small, single-cohort cross-sectional association with no causal direction established and explicit need for replication in larger, ethnically defined cohorts.
Evaluated 13 Nov 2026 · GBD 2023 · glm_v1_3_3 · impact_profile_v1_3_3
AI-generated, human-governed. Something look off? Contact us to request a review.
Keep reading
Other papers Nabu has evaluated blind, starting with the same field.
Weiser-Fuchs, Maggauer, van Poppel, et al. · 2023 · Health sciences
Serum 3'SL concentrations significantly increased from fasting to 1 h after glucose load, while concentrations of the other HMOs were unaltered.
TentativeNeumann, Mahnert, Kumpitsch, et al. · 2023 · Clinical medicine
We demonstrate that preventive regimens have the highest impact on development and maturation of the gastrointestinal microbiome, enabling the establishment of a resilient microbial ecosystem that reduces pathogenic threats in at-risk preterm infants.
TentativeKurath-Koller, Neumann, Moissl-Eichinger, et al. · 2020 · Clinical medicine
We found that hospital regimens significantly influenced the microbiome composition, diversity and quantity right from the beginning and all the way up to the more mature microbiome starting from two to three weeks of age onwards.
Tentative